Key Takeaway: The article discusses the upcoming EAU 2025 conference, focusing on translational correlates using urinary minimal residual disease (MRD). It highlights the significance of this research in the field. Further details about presentations and related activities are mentioned, but specifics are limited.
Price reaction · baseline $16.97 (2025-04-04T17:23:00.000Z) · hit during market hours · clean, no other CGON news in the window
day 0 close · peak
+1.4%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+139%
120-day peak, hindsight
Typical move
6.3%
average across 5 past catalysts
Cash runway
~66 mo
Minimal dilution risk
Lead asset
CG0070
Phase 2 · Non Muscle Invasive Bladder Cancer
Full Press Release Details
Press Releases
Video Library
Careers
EAU 2025 TRANSLATIONAL CORRELATES USING URINARY MRD